CUBE Tech Fair welcomes spectacular speakers

CUBE10 - 12 May 2017, Berlin, Germany.
CUBE Tech Fair welcomes Brigitte Zypries, Germany's Federal Minister for Economic Affairs and Energy. CUBE is inspired by her work at the Ministry of Economics, in which she places a strong emphasis on advancing the Industry 4.0. She supports startups as well as SMBs (small & medium-sized businesses), where she promotes various financial instruments and network opportunities offered by the BMWi.

More Speakers

Samantha Payne

Founder of Open Bionics
Co-Founder of Open Bionics; an award-winning startup developing low-cost bionic hands that look and feel good, for amputees or those born without a hand. Now part of the Disney Accelerator, powered by Techstars. Samantha, recently named as one of the top 25 women in robotics you need to know about by Robohub and Marie Claire's Top Women In Tech. The startup has won multiple other awards for innovation, including being named one of the top 50 robotics businesses in the world alongside Google and Amazon.

Pablos Holman

Futurist, inventor, and notorious hacker.
He has helped create the world's smallest PC; 3D printers at Makerbot; & spaceships with Jeff Bezos. Currently, Pablos is working for Nathan Myhrvold & Bill Gates at the Intellectual Ventures Laboratory inventing solutions to the world's biggest problems.

Jonathan Yoni Ofir

CEO of LEAF
LEAF is the plug-n-plant™ system that automatically grows medical plants and food from the comfort of your home. Yoni founded LEAF in 2015 after he decided to build a growing system for his own needs and encountered overwhelming consumer demand. In September 2015 LEAF was the first ever cannabis startup to participate in Techrunch Disrupt Battlefield. LEAF was named Product Hunt 2016 Hardware Product of the Year and was featured on VICELAND's Weediquette.

Joseph Brunner

CEO of Relayr
Josef Brunner serves as relayr’s Chief Executive Officer. Josef has been instrumental in launching multiple IT and Cyber Security companies, like JouleX (2009) and Bastille Networks (2004). Before starting relayr, he completed his tenure with Cisco Systems, which began after the 2013 Cisco acquisition of JouleX, where he was Co-Founder and Chief Architect. Josef is also an active venture capitalist through his venture capital firm AFT Ventures.

World Pharma News readers can benefit from an exclusive discount - get 30% off the ticket price using our unique promo code worldpharmanewsCUBE17 when you register online here.

Hint: The faster you buy your ticket, the cheaper it is.

About CUBE
CUBE is a Berlin-based global innovation ecosystem that aims to promote, create and foster partnerships between industry players and startups in life sciences & digital health, machinery & manufacturing as well as infrastructure & connectivity. Being part of the CUBE ecosystem allows all participants to collaborate on innovative products and ideas in response to concrete industry needs.

The annual CUBE Tech Fair, our flagship event, will take place for the first time in May 2017. For further information, please visit http://tech-fair.cube-global.com.

Most Popular Now

FDA takes action against 14 companies for selling …

The U.S. Food and Drug Administration today posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to...

Read more

Merck divests Biosimilars business to Fresenius

Merck, a leading science and technology company, has announced the divestment of its Biosimilars business to Fresenius. The decision to divest Biosimilars is aligned with...

Read more

FDA approves drug to treat ALS

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's...

Read more

AstraZeneca marks a key milestone with the ‘toppin…

AstraZeneca marks a key milestone in its successful move to Cambridge, UK, with the 'topping out' of its new, state-of-the-art, strategic R&D centre and global corporate ...

Read more

FDA approves first treatment for a form of Batten …

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved ...

Read more

Abbott announces CE Mark and first use of the worl…

Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will h...

Read more

Italian-style coffee reduces the risk of prostate …

Add another typical component of the Italian way of life to the long list of foods characterizing one of the most healthy populations in the world. This time it's coffee...

Read more

Antibiotic doxycycline may offer hope for treatmen…

A study published in the journal Scientific Reports suggests that doxycycline, an antibiotic used for over half a century against bacterial infections, can be prescribed ...

Read more

Novartis exercises exclusive option agreement with…

Novartis announced today that it has notified Conatus Pharmaceuticals Inc., of its exercise of the option to an exclusive license for the global development and commercia...

Read more

England's Cancer Drugs Fund 'failed to deliver mea…

Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund (CDF) in England has shown that the fund was not good value for patients and society and may...

Read more

Imfinzi significantly reduces the risk of disease …

AstraZeneca and MedImmune, its global biologics research and development arm, today announced positive results for the Phase III PACIFIC trial, a randomised, double-blind...

Read more

Vitamin A deficiency is detrimental to blood stem …

Many specialized cells, such as in the skin, gut or blood, have a lifespan of only a few days. Therefore, steady replenishment of these cells is indispensable. They arise...

Read more

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]